ITMI910618A1 - Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali - Google Patents

Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali

Info

Publication number
ITMI910618A1
ITMI910618A1 IT000618A ITMI910618A ITMI910618A1 IT MI910618 A1 ITMI910618 A1 IT MI910618A1 IT 000618 A IT000618 A IT 000618A IT MI910618 A ITMI910618 A IT MI910618A IT MI910618 A1 ITMI910618 A1 IT MI910618A1
Authority
IT
Italy
Prior art keywords
diaza
aza
nitrogen oxides
anthrocenedionic
derivatives
Prior art date
Application number
IT000618A
Other languages
English (en)
Inventor
Marcello Allegretti
Alberto Bernareggi
Dott Ciccarelli S P A Farmaceutici
Ambrogio Oliva
Sergio Tognella
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Publication of ITMI910618A0 publication Critical patent/ITMI910618A0/it
Priority to ITMI910618A priority Critical patent/IT1244755B/it
Priority to AT92905365T priority patent/ATE167856T1/de
Priority to JP4504948A priority patent/JPH06505244A/ja
Priority to DE69226091T priority patent/DE69226091D1/de
Priority to PCT/EP1992/000421 priority patent/WO1992015566A1/en
Priority to AU12768/92A priority patent/AU1276892A/en
Priority to EP92905365A priority patent/EP0639183B1/en
Priority to AT92905252T priority patent/ATE123220T1/de
Priority to MX9200919A priority patent/MX9200919A/es
Priority to IL10115792A priority patent/IL101157A/en
Priority to TW081101691A priority patent/TW197426B/zh
Priority to ZA921648A priority patent/ZA921648B/xx
Priority to IE070492A priority patent/IE920704A1/en
Priority to NZ241856A priority patent/NZ241856A/en
Publication of ITMI910618A1 publication Critical patent/ITMI910618A1/it
Application granted granted Critical
Publication of IT1244755B publication Critical patent/IT1244755B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI910618A 1991-03-08 1991-03-08 Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali IT1244755B (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ITMI910618A IT1244755B (it) 1991-03-08 1991-03-08 Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali
EP92905365A EP0639183B1 (en) 1991-03-08 1992-02-27 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents
JP4504948A JPH06505244A (ja) 1991-03-08 1992-02-27 アザ−およびジアザ−アントラセンジオン誘導体の抗腫瘍剤としての窒素酸化物
DE69226091T DE69226091D1 (de) 1991-03-08 1992-02-27 Stickstoffoxide von aza- und diazaanthracendionderivaten, deren herstellung und deren verwendung als antitumormittel
PCT/EP1992/000421 WO1992015566A1 (en) 1991-03-08 1992-02-27 Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents
AU12768/92A AU1276892A (en) 1991-03-08 1992-02-27 Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents
AT92905365T ATE167856T1 (de) 1991-03-08 1992-02-27 Stickstoffoxide von aza- und diazaanthracendionderivaten, deren herstellung und deren verwendung als antitumormittel
AT92905252T ATE123220T1 (de) 1991-03-08 1992-03-02 6,9-bis(amino substituierte) benzo(g)phthalazin- 5,10-dionen als antikrebs-mittel.
MX9200919A MX9200919A (es) 1991-03-08 1992-03-03 Oxidos de nitrogenos de derivados azo - y diazo - antrasenoides como agentes antitumorales.
IL10115792A IL101157A (en) 1991-03-08 1992-03-05 History of aza- and diazea-anthracenedione N-oxides, process for their preparation and anigoidal preparations containing them
TW081101691A TW197426B (it) 1991-03-08 1992-03-05
ZA921648A ZA921648B (en) 1991-03-08 1992-03-05 Nitrogen oxides of aza-and diaza-anthracenedione derivatives as antitumor agents
IE070492A IE920704A1 (en) 1991-03-08 1992-03-05 Nitrogen oxides of aza- and diaza-anthracenedione¹derivatives as antitumor agents
NZ241856A NZ241856A (en) 1991-03-08 1992-03-05 N-oxides of aza-anthracenedione derivatives, preparation and pharmaceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910618A IT1244755B (it) 1991-03-08 1991-03-08 Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali

Publications (3)

Publication Number Publication Date
ITMI910618A0 ITMI910618A0 (it) 1991-03-08
ITMI910618A1 true ITMI910618A1 (it) 1992-09-08
IT1244755B IT1244755B (it) 1994-08-08

Family

ID=11358951

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910618A IT1244755B (it) 1991-03-08 1991-03-08 Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali

Country Status (13)

Country Link
EP (1) EP0639183B1 (it)
JP (1) JPH06505244A (it)
AT (2) ATE167856T1 (it)
AU (1) AU1276892A (it)
DE (1) DE69226091D1 (it)
IE (1) IE920704A1 (it)
IL (1) IL101157A (it)
IT (1) IT1244755B (it)
MX (1) MX9200919A (it)
NZ (1) NZ241856A (it)
TW (1) TW197426B (it)
WO (1) WO1992015566A1 (it)
ZA (1) ZA921648B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557704B (zh) * 2013-10-28 2017-05-10 北京凯莱天成医药科技有限公司 一种匹杉琼马来酸盐的制备方法
CN103787970A (zh) * 2014-01-14 2014-05-14 北京万全德众医药生物技术有限公司 一锅煮法制备6,9-二氟苯并异喹啉-5,10-二酮的工艺
CN106366036B (zh) * 2016-08-18 2019-07-09 湖北丽益医药科技有限公司 6,9-双[(2-氨基乙基)氨基]苯并[g]异喹啉-5,10-二酮二马来酸盐及其合成工艺

Also Published As

Publication number Publication date
EP0639183A1 (en) 1995-02-22
IT1244755B (it) 1994-08-08
NZ241856A (en) 1994-12-22
DE69226091D1 (de) 1998-08-06
IE920704A1 (en) 1992-09-09
IL101157A (en) 1996-07-23
JPH06505244A (ja) 1994-06-16
MX9200919A (es) 1992-09-30
TW197426B (it) 1993-01-01
ATE123220T1 (de) 1995-06-15
ZA921648B (en) 1992-11-25
ATE167856T1 (de) 1998-07-15
AU1276892A (en) 1992-10-06
WO1992015566A1 (en) 1992-09-17
EP0639183B1 (en) 1998-07-01
ITMI910618A0 (it) 1991-03-08

Similar Documents

Publication Publication Date Title
YU176191A (sh) Derivati hinazolina za pojačavanje antitumorne aktivnosti
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
DE69709407D1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
NO932954D0 (no) 2,4-diaminokinazolin-derivater for aa oppnaa oeket antitumoraktivitet
IE861997L (en) Zwitterionic bicyclic compounds
ATE234636T1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
ITMI910618A1 (it) Azoto ossidi di derivati aza- e diaza-antracenedionici come farmaci antitumorali
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ATE381944T1 (de) Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten
MX9702671A (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
IT8922175A0 (it) Derivati amminici di 2,3-diaza-antracene-9,10-dioni come farmaci antitumorali
IL167920A (en) An in vitro cell method to generate covalent ligand between the erythropoietin and poly (ethylene glycol) peptide, such medicinal preparations containing said covalent ligand, and its use in the preparation of drugs to stimulate culture, differentiation, and activation of primary myeloid cells
ITMI932377A1 (it) Composizioni terapeutiche ad attivita' antitumorale a base di derivati 1,3,8,10 tetrasostituiti del 4,5,6,7-tetratiocino-(1,2-b: 3,4-b')-

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329